United States
China
India
Japan
Singapore
South Africa
United Kingdom
As a leading publisher of trusted science, technology, medicine, humanities and social sciences research, Taylor & Francis is committed to helping public health authorities, researchers, clinicians and the general public contain and manage the spread of COVID-19.
This microsite provides links and references to all relevant COVID-19 research articles, book chapters and information that can be freely accessed on Taylor & Francis Online and Taylor & Francis ebooks in support of the global efforts in diagnosis, treatment, prevention and further research into COVID-19. As signatories to NIH’s Access to Research initiative, along with the Wellcome Trust’s coordinated action on sharing research data and findings relevant to the outbreak, Taylor & Francis has been working with WHO to ensure this content is clearly signposted. We are also aligning the OSTP’s initiative to centralise resources on PubMed and are currently working with them to ensure rapid human and machine-readable access (where possible) to research articles and data through the NLM’s LitCovid portal.
More research in this field has been collated by colleagues at F1000Research, through a dedicated Gateway which showcases research published in this area, including preprints, to ensure immediate access to the latest research developments https://f1000research.com/gateways/disease_outbreaks/coronavirus
Prioritising rapid publication of COVID-19 materials
We are working with our editors to prioritise peer review of all relevant research. We are also focusing our workflow to ensure that materials related to the outbreak are fast-tracked through the publication process once they are approved. Editors are proactively encouraging authors to publish and share the data that forms the basis of their research in line with FAIR data principles, and our own data policies.
We are continually monitoring the developments of the coronavirus and spread of COVID-19, and we will continue to update the content on this site on a regular basis.
Journals
1-168 of 4,900+ results.
Access the full Coronavirus Research Archive
- research-articleHigh rate of bacterial respiratory tract co-infections upon admission amongst moderate to severe COVID-19 patients
- research-articleIdentification of potent inhibitors against transmembrane serine protease 2 for developing therapeutics against SARS-CoV-2
- otherTherapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19
- research-articleLower plasma calcium associated with COVID-19, but not with disease severity: a two-centre retrospective cohort study
- research-articleInvestigation of MBL2 and NOS3 functional gene variants in suspected COVID-19 PCR (–) patients
- research-articleCan Anakinra and corticosteroid treatment be an effective option in pregnant women with severe Covid-19?
- rapid-communicationDuplex formation between the template and the nascent strand in the transcription-regulating sequences is associated with the site of template switching in SARS – CoV-2
- research-articleArjunetin as a promising drug candidate against SARS-CoV-2: molecular dynamics simulation studies
- research-articleAntibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh
- research-articleAntibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh
- research-articleDrug repositioning against COVID-19: a first line treatment
- research-articleDetection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition
- review-articleNuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment
- research-articleUnderstanding the molecular interaction of SARS-CoV-2 spike mutants with ACE2 (angiotensin converting enzyme 2)
- research-articleIn silico prediction of natural compounds as potential multi-target inhibitors of structural proteins of SARS-CoV-2
- research-articleFeaturing ACE2 binding SARS-CoV and SARS-CoV-2 through a conserved evolutionary pattern of amino acid residues
- research-articleDiscovery of novel inhibitors of SARS-CoV-2 main protease
- research-articleRelation of interleukin-6 levels in COVID-19 patients with major adverse cardiac events
- otherTo mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination
- research-articleAssociation between Vitamin D Status and Risk of Developing Severe COVID-19 Infection: A Meta-Analysis of Observational Studies
- research-articleMyxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein
- research-articleMyxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein
Books
- research-articleAn overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19)
- research-articleThe role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism
- research-articleCOVID-19 clinical phenotypes and short-term outcomes: differences between the first and the second wave of pandemic in Italy
- research-articleRepurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2
- research-articleTocilizumab for the treatment of non‐critical COVID‐19 pneumonia: an overview of the rationale and clinical evidence to date
- article-commentarySARS-CoV-2 vaccination in the context of original antigenic sin
- research-articleHuman immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants
- research-articleTocilizumab in COVID-19: a study of adverse drug events reported in the WHO database
- research-articleBlood concentrations of proapoptotic sFas and antiapoptotic Bcl2 and COVID-19 patient mortality
- research-articleAssociation between Hb A1c and Severity of COVID-19 Patients
- research-articleEmerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
- research-articleIntegrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors
- research-articleIntegrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors
- research-articlePerformance of the FREND™ COVID-19 IgG/IgM Duo point-of-care test for SARS-CoV-2 antibody detection
- research-articleReported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST)
- otherUnleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination
- research-articleChemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications
- research-articleMolecular modeling of potent novel sulfonamide derivatives as non-peptide small molecule anti-COVID 19 agents
- research-articleAre the new SARS-CoV-2 variants resistant against the vaccine?
- research-articleHospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
- research-articlePotential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations
- research-articleThe role of IL-6 and IL-6 blockade in COVID-19
- research-articleEngineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins
- research-articleVirtual screening of quinoline derived library for SARS-COV-2 targeting viral entry and replication
- review-articleLong COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
- research-articleMarine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery
- research-articleA large-scale computational screen identifies strong potential inhibitors for disrupting SARS-CoV-2 S-protein and human ACE2 interaction
- research-articleDistinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-19
- research-articlePerspective: the nose and the stomach play a critical role in the NZACE2-Pātari* (modified ACE2) drug treatment project of SARS-CoV-2 infection
- research-articleThe Glasgow Prognostic Score and fibrinogen to albumin ratio as prognostic factors in hospitalized patients with COVID-19
- research-articleComputational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings
- otherTapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population
- case-reportHemorrhagic infarctive stroke in COVID-19 patients: report of two cases and review of the literature
- review-articleCOVID-19 pericarditis mimicking an acute myocardial infarction: a case report and review of literature
- research-articleOutcomes of acute respiratory distress syndrome in COVID-19 patients compared to the general population: a systematic review and meta-analysis
- article-commentaryIs a single COVID-19 vaccine dose enough in convalescents ?
- article-commentaryExperimental studies using OMV in a new platform of SARS-CoV-2 vaccines
- Original ResearchStructural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach
- Original ResearchDesign of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach